SCHEMBL7708513

SCHEMBL7708513

Cc1cc(O)c2ccccc2c1OCC(O)CN1CCN(c2ccccc2O)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.53
ALDH1A1 P00352 4/20 0.53
MAPK1 P28482 3/20 0.53
GAA P10253 2/20 0.53
MEN1 O00255 6/20 0.53
KMT2A Q03164 6/20 0.53
HSP90AB1 P08238 1/20 0.53
KDM4E B2RXH2 3/20 0.52
HTT P42858 2/20 0.52
LMNA P02545 4/20 0.51
TDP1 Q9NUW8 2/20 0.51
HIF1A Q16665 2/20 0.51
NR1I2 O75469 1/20 0.51
NR3C1 P04150 1/20 0.51
ADRB1 P08588 1/20 0.51
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51
DRD2 P14416 1/20 0.51
ADRA2B P18089 1/20 0.51
ADRA2C P18825 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7705089 0.99 MAPT (0.55) MAPTALDH1A1MAPK1GAAMEN1
SCHEMBL7711449 0.94 ABCB1 (0.58) ABCB1
Hydrochloric Acid SCHEMBL7708545 0.93 GAA (0.57) MAPTALDH1A1MAPK1GAAABCB1
SCHEMBL7987892 0.90 MAPT (0.69) MAPTALDH1A1MAPK1MEN1KMT2A
Hydrochloric Acid SCHEMBL7708335 0.89 MAPT (0.71) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL7705073 0.86 ALDH1A1 (0.59) MAPTALDH1A1MAPK1GAAMEN1
Hydrochloric Acid SCHEMBL7711386 0.85 ALDH1A1 (0.61) MAPTALDH1A1MAPK1GAAMEN1
SCHEMBL7708368 0.85 ALDH1A1 (0.74) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL7711004 0.85 MAPT (0.57) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL7705108 0.85 MAPT (0.57) MAPTALDH1A1MAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358515-B2 ANTIHYPERTENSIVE PHARMACEUTICAL COMPOSITION; TREATMENT OF GLAUCOMA SENJU PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US claimed
US-20010008893-A1 HYDROQUINONE DERIVATIVES SENJU PHARMACEUTICAL CO., LTD. (JP) 2001-07-19 US claimed
EP-0972766-A1 HYDROQUINONE DERIVATIVES Senju Pharmaceutical Co., Ltd. (JP) 2000-01-19 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008893-A1 HYDROQUINONE DERIVATIVES REN, AGTR1, AGTR2 MAPT 4729/4885ALDH1A1 128/4885MAPK1 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.